Blood product transfusions are associated with an increase in serum (1-3)-beta-d-glucan in infants during the initial hospitalization in neonatal intensive care unit (NICU)

References

• Benjamin DK, Stoll BJ, Gantz MG, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 2010;126:e865–73.
   PubMed Web of Science ®Google Scholar
• Prowle JR, Echeverri JE, Ligabo EV, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care 2011;15:R100.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Guimarães T, Sukienik T, et al. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med 2014;40:1489–98.
   PubMed Web of Science ®Google Scholar
• Aliaga S, Clark RH, Laughon M, et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics 2014;133:236–42.
   PubMed Web of Science ®Google Scholar
• Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006;43:25–31.
   PubMed Web of Science ®Google Scholar
• Cahan H, Deville JG. Outcomes of neonatal candidiasis: the impact of delayed initiation of antifungal therapy. Int J Pediatr 2011;2011:813871.
   PubMedGoogle Scholar
• Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med 2012;125:S14–24.
   PubMed Web of Science ®Google Scholar
• Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J Microbiol 2005;43:65–84.
   PubMed Web of Science ®Google Scholar
• Benjamin DK, Poole C, Steinbach WJ, et al. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003;112:634–40.
   PubMed Web of Science ®Google Scholar
• Poissy J, Sendid B, Damiens S, et al. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation. Crit Care 2014;18:R135.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh T, Donnelly J, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813–21.
   PubMed Web of Science ®Google Scholar
• Montagna MT, Lovero G, De Giglio O, et al. Invasive fungal infections in neonatal intensive care units of Southern Italy: a multicentre regional active surveillance (AURORA project). J Prev Med Hyg 2010;51:125–30.
   PubMedGoogle Scholar
• Goudjil S, Kongolo G, Dusol L, et al. (1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate. J Matern Fetal Neonatal Med 2013;26:44–8.
   PubMed Web of Science ®Google Scholar
• Zhao D, Qiu G, Luo Z, Zhang Y. Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants. PLoS One 2015;10:e0123907.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Sant HW, Bowles CA, et al. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005;43:5957–62.
   PubMed Web of Science ®Google Scholar
• Kato A, Takita T, Furuhashi M, et al. Elevation of blood (1->3)-beta-D-glucan concentrations in hemodialysis patients. Nephron 2001;89:15–19.
   PubMed Web of Science ®Google Scholar
• Kanamori H, Kanemitsu K, Miyasaka T, et al. Measurement of (1-3)-beta-D-glucan derived from different gauze types. Tohoku J Exp Med 2009;217:117–21.
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Warris A, Verweij PE. 1,3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid. N Engl J Med 2006;354:2834–5.
   PubMed Web of Science ®Google Scholar
• Metan G, Ağkuş C, Buldu H, Koç AN. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections. Infection 2010;38:217–21.
   PubMed Web of Science ®Google Scholar
• Digby J, Kalbfleisch J, Glenn A, et al. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 2003;10:882–5.
   PubMedGoogle Scholar
• Mennink-Kersten MA, Ruegebrink D, Verweij PE. Pseudomonas aeruginosa as a cause of 1,3-beta-D-glucan assay reactivity. Clin Infect Dis 2008;46:1930–1.
   PubMed Web of Science ®Google Scholar
• Albert O, Toubas D, Strady C, et al. Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 2011;30:1453–60.
   PubMed Web of Science ®Google Scholar
• Usami M, Ohata A, Horiuchi T, et al. Positive (1–>3)-beta-D-glucan in blood components and release of (1–>3)-beta-D-glucan from depth-type membrane filters for blood processing. Transfusion 2002;42:1189–95.
   PubMed Web of Science ®Google Scholar
• Lo Cascio G, Koncan R, Stringari G, et al. Interference of confounding factors on the use of (1,3)-beta-D-glucan in the diagnosis of invasive candidiasis in the intensive care unit. Eur J Clin Microbiol Infect Dis 2015;34:357–65.
   PubMed Web of Science ®Google Scholar
• Martín-Mazuelos E, Loza A, Castro C, et al. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis. Intensive Care Med 2015;41:1424–32.
   PubMed Web of Science ®Google Scholar
• Hammarström H, Kondori N, Friman V, Wennerås C. How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors. Eur J Clin Microbiol Infect Dis 2015;34:917–25.
   PubMed Web of Science ®Google Scholar
• Manzoni P, Farina D, Galletto P, et al. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med 2007;35:220–6.
   PubMed Web of Science ®Google Scholar
• Ali GY, Algohary EH, Rashed KA, et al. Prevalence of Candida colonization in preterm newborns and VLBW in neonatal intensive care unit: role of maternal colonization as a risk factor in transmission of disease. J Matern Fetal Neonatal Med 2012;25:789–95.
   PubMed Web of Science ®Google Scholar
• Manzoni P, Farina D, Leonessa M, et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006;118:2359–64.
   PubMed Web of Science ®Google Scholar
• Racil Z, Kocmanova I, Lengerova M, et al. Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies – high frequency of false-positive results and their analysis. J Med Microbiol 2010;59:1016–22.
   PubMed Web of Science ®Google Scholar